Viral hepatitis and HIV coinfection
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology · doi:10.1002/hep.21178 · Cited by 5,021 · cited 1×
“Currently a number of tests are available which can reliably separate patients with minimal fibrosis from those with cirrhosis but fail to clearly distinguish intermediate stages of fibrotic disease progression [41–45].”
BackgroundRisk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Epidemiology of viral hepatitis and HIV co-infection
Alter, M. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.004 · Cited by 1,012
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Wulfsohn, M. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021812 · Cited by 995
Graham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Self-citationGreub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Burgisser, P., Erb, P., Boggian, K., Piffaretti, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03232-3 · Cited by 894
Chung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
Sherman, K. E., Rouster, S. D., Chung, R. T., & Rajicic, N. (2002) · Clinical Infectious Diseases · doi:10.1086/339042 · Cited by 733
Konopnicki, D., Mocroft, A., de Wit, S., Antunes, F., Ledergerber, B., Katlama, C., Zilmer, K., Vella, S., Kirk, O., & Lundgren, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000163936.99401.fe · Cited by 569
Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00939-9 · Cited by 564
Yim, H. J., & Lok, A. S.-F. (2006) · Hepatology · doi:10.1002/hep.20956 · Cited by 545
Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., & Spengler, U. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14844-1 · Cited by 525
Sulkowski, M. S., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30319 · Cited by 523
Self-citationSharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500
Darby, S. C., Ewart, D. W., Giangrande, P. L., Spooner, R. J., Rizza, C. R., Dusheiko, G. M., Lee, C. A., Ludlam, C. A., & Preston, F. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05413-5 · Cited by 497
LAI, C., LEUNG, N., TEO, E., TONG, M., WONG, F., HANN, H., HAN, S., POYNARD, T., MYERS, M., & CHAO, G. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.053 · Cited by 449
Hepatitis C and Progression of HIV Disease
Sulkowski, M. S. (2002) · JAMA · doi:10.1001/jama.288.2.199 · Cited by 445
Self-citationSoriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Self-citationBenhamou, Y., Bochet, M., Thibault, V., Di Martino, V., Caumes, E., Bricaire, F., Opolon, P., Katlama, C., & Poynard, T. (1999) · Hepatology · doi:10.1002/hep.510300525 · Cited by 424
Benhamou, Y., Di Martino, V., Bochet, M., Colombet, G., Thibault, V., Liou, A., Katlama, C., & Poynard, T. (2001) · Hepatology · doi:10.1053/jhep.2001.26517 · Cited by 424
Eyster, M. E., Diamondstone, L. S., Lien, J., Ehmann, W. C., Quan, S., & Goedert, J. J. (1993) · PubMed · Cited by 421
Danta, M., Brown, D., Bhagani, S., Pybus, O. G., Sabin, C. A., Nelson, M., Fisher, M., Johnson, A. M., & Dusheiko, G. M. (2007) · AIDS · doi:10.1097/qad.0b013e3281053a0c · Cited by 410
Hepatitis C in the HIV-Infected Person
Sulkowski, M. S., & Thomas, D. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00012 · Cited by 405 · cited 1×
“Based on the relative efficiency of transmission, the prevalence of HCV coinfection varies depending on the route of HIV transmission, ranging from 10% to 14% among persons reporting high-risk sexual exposure to approximately 85–90% among those reporting IDU [16].”
BackgroundSelf-citationProgression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
Mast, E. E., Hwang, L., Seto, D. S. Y., Nolte, F. S., Nainan, O. V., Wurtzel, H., & Alter, M. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497701 · Cited by 396
van Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389
Laguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., Bargallo, X., García-Criado, A., Lazzari, E. D., Larrousse, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00003 · Cited by 387
Rockstroh, J. K., Mocroft, A., Soriano, V., Tural, C., Losso, M. H., Horban, A., Kirk, O., Phillips, A., Ledergerber, B., Lundgren, J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/432762 · Cited by 383
Alberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Correlates of Hepatitis C Virus Infections among Injection Drug Users
Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., & Nelson, K. E. (1995) · Medicine · doi:10.1097/00005792-199507000-00005 · Cited by 362
de Lédinghen, V., Douvin, C., Kettaneh, A., Ziol, M., Roulot, D., Marcellin, P., Dhumeaux, D., & Beaugrand, M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000194238.15831.c7 · Cited by 354
Soriano, V., Puoti, M., Sulkowski, M., Cargnel, A., Benhamou, Y., Peters, M., Mauss, S., Bräu, N., Hatzakis, A., Pol, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3281084e4d · Cited by 349
Self-citationViral Hepatitis in HIV Infection
Koziel, M. J., & Peters, M. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065142 · Cited by 322
Wit, F. W. N. M., Weverling, G. J., Weel, J., Jurriaans, S., & Lange, J. M. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341084 · Cited by 315
The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance
McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067710 · Cited by 292
van de Laar, T. J. W., van der Bij, A. K., Prins, M., Bruisten, S. M., Brinkman, K., Ruys, T. A., van der Meer, J. T. M., Vries, H. J. C. D., Mulder, J., Agtmael, M. V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518796 · Cited by 284 · cited 1×
“For example, in one cohort, the incidence of HCV infection among HIV seropositive MSMs increased 10-fold after 2000 [14].”
BackgroundKellerman, S. E., Hanson, D. L., McNaghten, A. D., & Fleming, P. L. (2003) · The Journal of Infectious Diseases · doi:10.1086/377135 · Cited by 282
Dore, G. J., Cooper, D. A., Pozniak, A. L., DeJesus, E., Zhong, L., Miller, M. D., Lu, B., Cheng, A. K., & Teams, T. 9. A. 9. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/380398 · Cited by 253
Fonseca, M. O., Pang, L. W., Cavalheiro, N. D. P., Barone, A. A., & Lopes, M. H. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.057 · Cited by 243
Thomas, D. L., Villano, S. A., Riester, K. A., Hershow, R., Mofenson, L. M., Landesman, S. H., Hollinger, F. B., Davenny, K., Riley, L., Diaz, C., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515315 · Cited by 239
Kelleher, T. B., Mehta, S. H., Bhaskar, R., Sulkowski, M., Astemborski, J., Thomas, D. L., Moore, R. E., & Afdhal, N. H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.025 · Cited by 227
Self-citationMyers, R. P., Benhamou, Y., Imbert-Bismut, F., Thibault, V., Bochet, M., Charlotte, F., Ratziu, V., Bricaire, F., Katlama, C., & Poynard, T. (2003) · AIDS · doi:10.1097/00002030-200303280-00010 · Cited by 203
Hofer, M., Joller-Jemelka, H. I., Grob, P. J., Lüthy, R., Opravil, M., & Study, S. H. C. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01584356 · Cited by 193
Peters, M. G., Andersen, J., Lynch, P., Liu, T., Alston-Smith, B., Brosgart, C. L., Jacobson, J. M., Johnson, V. A., Pollard, R. B., Rooney, J. F., et al. (2006) · Hepatology · doi:10.1002/hep.21388 · Cited by 180
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus
Sulkowski, M. S., Mehta, S. H., Torbenson, M., Afdhal, N. H., Mirel, L., Moore, R. D., & Thomas, D. L. (2005) · AIDS · doi:10.1097/01.aids.0000163935.99401.25 · Cited by 177
Self-citationEnd-stage liver disease in persons with hemophilia and transfusion-associated infections.
Goedert, J. J., Eyster, M. E., Lederman, M. M., Mandalaki, T., de Moerloose, P., White, G., Angiolillo, A. L., Luban, N. L. C., Sherman, K. E., Manco‐Johnson, M. J., et al. (2002) · PubMed · Cited by 171
Macías, J., Castellano, V., Merchante, N., Palacios, R. B., Mira, J. A., Sáez, C., García-García, J. A., Lozano, F., Gómez-Mateos, J. M., & Pineda, J. A. (2004) · AIDS · doi:10.1097/00002030-200403260-00007 · Cited by 167
Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs
Maida, I., Núñez, M., Ríos, M. J., Martín-Carbonero, L., Sotgiu, G., Toro, C., Rivas, P., Barreiro, P., Mura, M. S., Babudieri, S., et al. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000221683.44940.62 · Cited by 167
Pol, S., Lamorthe, B., Thi, N. T., Thiers, V., Carnot, F., Zylberberg, H., Berthelot, P., Bréchot, C., & Nalpas, B. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80341-3 · Cited by 165
Chung, R. T., Evans, S. R., Yang, Y., Theodore, D., Valdez, H., Clark, R., Shikuma, C., Nevin, T., & Sherman, K. E. (2002) · AIDS · doi:10.1097/00002030-200209270-00008 · Cited by 160
Thomas, D. L., Cannon, R. O., Shapiro, C. N., Hook, E. W., Alter, M. J., & Quinn, T. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.990 · Cited by 149
Thio, C. L. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39951 · Cited by 148
Aranzabal, L., Casado, J. L., Moya, J. L., Quereda, C., Diz, S. D. L., Moreno, A., Moreno, L., Antela, A., Pérez-Elías, M. J., Dronda, F., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427216 · Cited by 148
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
Mocroft, A., Soriano, V., Rockstroh, J. K., Reiss, P., Kirk, O., Wit, S. D., Gatell, J. M., Clotet, B., Phillips, A. N., & Lundgren, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000194799.43799.ea · Cited by 133
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
Mehta, S. H., Lucas, G. M., Mirel, L. B., Torbenson, M. S., Higgins, Y., Moore, R. D., Thomas, D. L., & Sulkowski, M. (2006) · AIDS · doi:10.1097/qad.0b013e32801086da · Cited by 133
Self-citationAlvarez, D., Dieterich, D. T., Bräu, N., Moorehead, L., Ball, L., & Sulkowski, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00749.x · Cited by 121
Self-citationProgression of liver fibrosis among injection drug users with chronic hepatitis C†
Wilson, L. E., Torbenson, M. S., Astemborski, J. A., Faruki, H., Spoler, C., Rai, R., Mehta, S. H., Kirk, G. D., Nelson, K. E., Afdhal, N. H., et al. (2006) · Hepatology · doi:10.1002/hep.21091 · Cited by 117
Gandhi, R. T., Wurcel, A. G., Lee, H., McGovern, B., Shopis, J., Geary, M., Sivamurthy, R., Sax, P. E., & Ukomadu, C. (2005) · The Journal of Infectious Diseases · doi:10.1086/429302 · Cited by 114
Mehta, S. H., Thomas, D. L., Torbenson, M. S., Brinkley, S., Mirel, L. B., Chaisson, R. E., Moore, R. D., & Sulkowski, M. (2005) · Hepatology · doi:10.1002/hep.20541 · Cited by 113
Self-citationThe Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV-Infected Persons
Mehta, S. H., Moore, R. D., Thomas, D. L., Chaisson, R. E., & Sulkowski, M. S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308150-00005 · Cited by 95
Self-citationHospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort
Gebo, K. A., Diener‐West, M., & Moore, R. D. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200310010-00006 · Cited by 92
Hope, V. D., Judd, A., Hickman, M., Lamagni, T. L., HUNTER, G. M., Stimson, G. V., Jones, S., Donovan, L., Parry, J. V., & Gill, O. N. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.38 · Cited by 80
End-stage liver disease in persons with hemophilia and transfusion-associated infections
(2003) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(03)90011-3 · Cited by 78
Bräu, N., Rodriguez‐Torres, M., Prokupek, D., Bonacini, M., Giffen, C. A., Smith, J. J., Frost, K. R., & Kostman, J. R. (2004) · Hepatology · doi:10.1002/hep.20107 · Cited by 71
Sullivan, P. S., Hanson, D. L., Teshale, E. H., Wotring, L. L., & Brooks, J. T. (2006) · AIDS · doi:10.1097/01.aids.0000226958.87471.48 · Cited by 64
Payan, C., Pivert, A., Morand, P., Fafi‐Kremer, S., Carrat, F., Pol, S., Cacoub, P., Perronne, C., Lunel, F., & the ANRS HC02 RIBAVIC study team (2007) · Gut · doi:10.1136/gut.2006.106690 · Cited by 52
Johnson, R. M., Ristig, M. B., Overton, E. T., Lisker‐Melman, M., Cummings, O. W., & Aberg, J. A. (2007) · HIV Clinical Trials · doi:10.1310/hct0803-173 · Cited by 26
Cited by
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, I., Razavi, H., & Vickerman, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00485-5 · Cited by 731
Metadata
- Authors
- Sulkowski, M. S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 48
- Issue
- 2
- Pages
- 353-367
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2054470549
- Cited by
- 316
- References
- 79
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.